Philip Ferneau serves as Executive at Compass Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Philip Ferneau has executed 3 insider transactions totaling $1.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 90,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | CMPX | $0 | Award | 90,000 | $N/A | Discretionary |
| Jun 19, 2020 | NONE | $1.3M | Purchase | 250,000 |
Philip Ferneau currently holds 90,000 shares of Compass Therapeutics, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip Ferneau has been a net buyer of NONE stock. They have purchased $1.6M and sold $0 worth of shares.
Philip Ferneau's most recent insider trade was on Jan 2, 2026, when they sold 90,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.00 |
| Discretionary |
| Jun 19, 2020 | NONE | $320.3K | Purchase | 64,066 | $5.00 | Discretionary |